ReAlta Life Sciences
Developing novel therapeutics for inflammatory and hypoxic diseases.
About
ReAlta Life Sciences is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for inflammatory and hypoxic diseases. Their lead candidate, Pegtarazimod, is being investigated for Hypoxic Ischemic Encephalopathy (HIE). The company leverages its proprietary platform to discover and develop treatments for a range of serious medical conditions.
Similar companies
Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
Shares Biotechnology, Pharmaceuticals
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Biotech
Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.
Shares Biotechnology, Healthcare
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Shares Biotechnology, Drug Discovery
Key facts
- Website
- realta.com
- Headquarters
- Norfolk, Virginia, USA
- Founded
- 2016
- Total funding
- $55M (Funding Round)
- Business model
- B2B
Funding rounds
- $40M8 Apr 2026Funding RoundLargest round
- $15M1 Mar 2021
Led by Deerfield Management
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 8 Apr 2026 | Funding Round | $40M | |
| 1 Mar 2021 | Series A | $15M | Deerfield Management |
Measured, not editorial
Agent Readiness
Measured by StartupHub.ai
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.25/100
Bottom 25%
Site Speed
Measured by Google PageSpeed
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.100/100
Top 25%
Data Trust
Measured by StartupHub.ai
Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.51/100
Below median · 1,337 scored
API & MCP Security
Measured by StartupHub.ai
What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.Test your Agent Readiness
How well ChatGPT, Claude and the other agents can read and use a site. About a minute.
Frequently asked
Is ReAlta Life Sciences trustworthy and reputable?
StartupHub's Data Trust & Reputation score for ReAlta Life Sciences is 51 out of 100, a use-caution rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has ReAlta Life Sciences raised?
ReAlta Life Sciences has raised a total of $55M in funding. The most recent round on record is Funding Round.
SEC filings, insider activity, nonprofit links and pay benchmarks for ReAlta Life Sciences:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

